Pharma-Bio Serv, Inc.
PBSV
$0.51
-$0.09-15.00%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,022.35% | -47.20% | 105.21% | -44.62% | 21.02% |
| Total Depreciation and Amortization | 19.69% | 9.25% | 4.73% | -0.67% | -1.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.90% | -429.27% | 166.10% | -426.13% | 93.37% |
| Change in Net Operating Assets | -39.50% | -1,486.84% | 93.43% | 33.29% | -146.54% |
| Cash from Operations | 29.78% | -647.83% | 111.70% | 4.34% | -196.53% |
| Capital Expenditure | -- | -- | -8,163.16% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -426.08% | 200.85% | -91.10% | 904.49% | 90.36% |
| Cash from Investing | -426.50% | 476.27% | -95.35% | 904.07% | 90.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 26.09% | 68.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | 99.90% | -23,852.78% |
| Foreign Exchange rate Adjustments | 369.63% | -582.14% | 60.56% | 64.32% | -264.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,065.91% | 118.37% | -91.79% | 203.67% | 27.98% |